Skip to main content

Table 2 Different clinical and laboratory parameters before and after iron therapy.

From: Obesity modulate serum hepcidin and treatment outcome of iron deficiency anemia in children: A case control study

  Obese children with IDA Non-obese children with IDA P value
  (n = 35) (n = 35)  
BMI (kg/m2)    
Baseline 25.70 ± 2.2 16.30 ± 1.9 <0.01
3 months after Fe therapy 25.91 ± 2.3 16.22 ± 1.2 <0.01
   p value >0.05 >0.05  
Hb (g/dl)    
Baseline 8.82 ± 1.2 8.22 ± 1.4 >0.05
3 months after Fe therapy 10.1 ± 0.8 12.8 ± 0.7 <0.05
   p value <0.05 <0.05  
Serum iron (ug/dl)    
Baseline 28.83 ± 2.5 29.28 ± 4.6 >0.05
3 months after Fe therapy 44.6 ± 6.9 65 ± 8.9 <0.05
   p value <0.05 <0.05  
TIBC (mg/dl)    
Baseline 491 ± 24 478 ± 15 >0.05
3 months after Fe therapy 385 ± 42 210 ± 23 <0.05
   p value <0.05 <0.05  
Serum ferritin (ng/ml)    
Baseline 51.91 ± 8.7 7.52 ± 1.6 <0.01
3 months after Fe therapy 52.19 ± 4.1 54.19 ± 4.1 >0.05
   p value >0.05 <0.01  
Serum hepcidin (nmol/L)    
Baseline 4.96 ± 1.2 0.11 ± 0.03 <0.01
3 months after Fe therapy 4.56 ± 1.4 1.62 ± 0.6 <0.01
   p value >0.05 <0.01  
  1. P > 0.05 = non-significant, P < 0.05 = significant, P < 0.01 highly significant. (Student t test).